$HHS

HARTE HANKS INC (HHS): Entry into a Material Definitive Agreement

HARTE HANKS INC (HHS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share Transaction Represents an Approximately 100% Premium to Harte Hanks' Unaffected Share Price Harte Hanks Shareholders to Receive 50% Cash and 50% in Star Equity 10% Pref

Original reporting
Published Aug 19, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$HHS
Bullish
high confidence
Mentioned
$HHS
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HHSBullishMed
01

Why it matters

The agreement removes a key execution hurdle, likely stabilizing the stock and enabling the deal to close, subject to regulatory approval.

02

Market read

The filing provides the first public confirmation of merger support, a material catalyst for HHS shareholders.

03

What to watch

Details of the merger valuation, financing terms, and integration risks are not disclosed.

Relevance 6/10Novelty 8/10Timing: filed Aug 19 2026

Background

Harte Hanks (HHS) filed an 8‑K reporting a Voting and Support Agreement with Star Equity Holdings, the parent of the merger sub, to secure shareholder votes for the merger.

Company-level read

Ticker impact

$HHSBullishHigh confidence
Context

Harte Hanks entered a Voting and Support Agreement to back a pending merger with Star Equity Holdings, a material definitive agreement disclosed in an 8‑K filing.

Expected impact

Potential upside as the merger proceeds, barring unexpected regulatory or shareholder opposition.

Evidence & confidence

First public disclosure of a binding merger support agreement; material to transaction completion.

Market effects

Consolidation in the marketing services sector may prompt peers to consider similar deals.

U.S. small‑cap market may see modest buying pressure on HHS and related stocks.

Limited to U.S. equities; no immediate global macro impact.

Counterpoint

If the merger faces antitrust scrutiny or shareholder dissent, the stock could decline despite the support agreement.

Key entities

  • Harte Hanks, Inc.

    U.S. marketing services firm, ticker HHS.

  • Star Equity Holdings, Inc.

    Parent company of the merger sub, involved in the pending merger.

Related articles

$HHSHighAI 9/10

Harte Hanks To Be Acquired By Star Equity For $38.4 Mln

Harte Hanks (HHS) and Star Equity Holdings (STRR) announced a merger in which Star Equity will acquire Harte Hanks for $5 per share, totaling about $38.4 million, about a 100% premium to Harte Hanks’ unaffected price, according to the companies. A 30-day go-shop runs until Sept. 13, with closing expected in 60 to 90 days. HHS was up 3.91% to $2.920 premarket.

$HHSHighAI 10/10

Harte Hanks, Inc.: Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Harte Hanks (NASDAQ:HHS) and Star Equity Holdings (NASDAQ:STRR) entered a definitive merger agreement under which Star Equity will acquire all Harte Hanks shares for $5.00 per share, about $38.4 million total equity value. Consideration is 50% cash and 50% Star Equity 10% preferred stock. Closing is expected in 60 to 90 days.

$HHSHighAI 9/10

Harte Hanks stock rises on $5 per share acquisition deal

Harte Hanks Inc (NASDAQ:HHS) shares rose 2.1% premarket after Star Equity Holdings Inc (NASDAQ:STRR) agreed to acquire HHS for $5.00 per share. The deal implies about $38.4M aggregate equity value, a 100% premium. HHS shareholders may take $5 cash or 0.50 shares of STRRP preferred. Board approved; expected close in 60-90 days.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$CVXMedAI 8/10

Chevron (CVX) Doubles Down on Venezuela with a $7 Billion Oil Bet

Chevron (CVX) plans to invest $7 billion in Venezuela over five years to double oil production to 600,000 barrels per day, adding areas in the Orinoco Belt to its joint venture with PDVSA. The move leverages Chevron's existing presence and aims for low-cost growth, despite political and regulatory risks. Venezuela holds the world's largest crude oil reserves but faces infrastructure challenges.

$LULULow

Lululemon Founder's $6.1B Fortune Thrown Into Chaos as He Divorces Wife of 20 Years With No Prenup

Lululemon founder Chip Wilson, estimated to have a $6.1B fortune, is divorcing his wife of 20 years without a prenuptial agreement. Under British Columbia law, their assets, including Wilson's 8.6% stake in Lululemon and 18% stake in Amer Sports, could be divided equally. The divorce may impact Lululemon's share price and market volatility, with analysts watching closely.